The Fit After Baby randomized controlled trial: An mHealth postpartum lifestyle intervention for women with elevated cardiometabolic risk.
Jacinda M NicklasLaura PyleAndrey SoaresJennifer A LeifermanSheana S BullSuhong TongAnn E CaldwellKatherine KuhnLinda A BarbourPublished in: PloS one (2024)
There were no significant differences between groups for postpartum weight loss for the entire study population. Among those unaffected by the COVID pandemic, women randomized to the FAB program lost significantly more weight than those randomized to the T4B program. The mHealth FAB program demonstrated a substantial level of engagement. Given the scalability and potential public health impact of the FAB program, the efficacy for decreasing cardiometabolic risk by increasing postpartum weight loss should be tested in a larger trial.
Keyphrases
- weight loss
- randomized controlled trial
- quality improvement
- public health
- bariatric surgery
- phase iii
- study protocol
- open label
- roux en y gastric bypass
- phase ii
- double blind
- clinical trial
- gastric bypass
- physical activity
- placebo controlled
- metabolic syndrome
- body mass index
- cardiovascular disease
- polycystic ovary syndrome
- pregnant women
- type diabetes
- systematic review
- skeletal muscle
- adipose tissue
- body weight
- insulin resistance
- obese patients